Devyser Diagnostics AB (publ) (STO: DVYSR)

Sweden flag Sweden · Delayed Price · Currency is SEK
113.50
-0.50 (-0.44%)
Aug 30, 2024, 5:29 PM CET
55.48%
Market Cap 1.87B
Revenue (ttm) 196.10M
Net Income (ttm) -54.20M
Shares Out 16.48M
EPS (ttm) -3.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,974
Open 114.00
Previous Close 114.00
Day's Range 112.00 - 115.00
52-Week Range 57.40 - 118.50
Beta 0.77
Analysts n/a
Price Target n/a
Earnings Date Oct 30, 2024

About Devyser Diagnostics AB

Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemia; breast, colorectal, and ovarian cancer; non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as acce... [Read more]

Sector Healthcare
Founded 2004
Employees 118
Stock Exchange Nasdaq Stockholm
Ticker Symbol DVYSR
Full Company Profile

Financial Performance

News

There is no news available yet.